ACTA1 and neoplasm: Immunohistochemical analysis showed that Exo-c-Jun-KO suppressed Ki-67, CD31 and α-SMA expression in the tumor section, and Exo-c-Jun-KO plus miR-494 agomir could neutralize such effect.